Inhalation Wednesday, April 25, 2018
Skip Navigation LinksHome) Item Details
Inhalation is the only technical publication devoted exclusively to readers involved in development and production of pulmonary or nasal delivered pharmaceuticals.
Technical Articles
Item Details:
Publication Date: 12/2010
Pages: 4
PDF Format
Recommended Item:
Developing OINDPs using Quality by Design

Providing key information to regulators may reduce costs and speed approval.

Recently, regulatory agencies have put greater emphasis on the need to understand pharmaceutical process, product quality and risk management to ensure that patient needs continue to be met. The United States Food and Drug Administration (FDA) Quality by Design (QbD) initiative encompasses these considerations, building on previous concepts covered in the International Conference on Harmonization (ICH) Q8 Pharmaceutical Development, ICH Q9 Quality Risk Management and ICH Q10 Pharmaceutical Quality Systems.

The QbD approach is meant to drive the drug development process to a proactive and holistic approach based on sound science, while managing risk. This is a deliberate design effort from initial product concept to commercialization meant to provide patients with a safe and effective drug product. As a result, product and process performance characteristics are scientifically designed to meet specific objectives, rather than being derived empirically from performance of test batches. Therefore, the opportunity exists to make changes within the established design space without the need for prior regulatory approval, ultimately reducing the overall approval time and number of product failures.

With that in mind, this article describes how understanding and applying the principles of QbD to analytical methods can ultimately save OINDP manufacturers time and money.

To read this entire article:

You may purchase this article now for personal use. Simply click the Buy Item button above, enter your payment details, and download the article. It will be available to you for 7 days for viewing, printing, or saving for future reference. All articles are copyrighted by CSC Publishing, Inc. and cannot be used for commercial purposes without express permission in writing from the Publisher. This includes but is not limited to: web posting, printing, or sharing via email.


Your payment information is forwarded in an encrypted form, using 40- or 128-bit Secure Socket Layer technology, only to our payment gateway ( for processing.


To view an article, you must have Acrobat Reader installed on your computer. Click on the icon to download Acrobat Reader free of charge.

      Copyright 2018, CSC Publishing Inc. ALL Rights Reserved * Privacy policy